CS
CRDF icon

Credit Suisse’s Cardiff Oncology CRDF Stock Holding History

Credit Suisse’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20
Closed – – 4073
2022
Q2 		$0 Buy
+20
New +$33 ﹤0.01% 3987
2021
Q1 		– Sell
-58,396
Closed -$1.05M – 4328
2020
Q4 		$1.05M Buy
+58,396
New +$1.03M ﹤0.01% 3306
2017
Q3 		– Sell
-157
Closed -$14K – 4181
2017
Q2 		$14K Buy
+157
New +$10.1K ﹤0.01% 3811
2017
Q1 		– Sell
-243
Closed -$37K – 3839
2016
Q4 		$37K Buy
243
+34
+16% +$7.94K ﹤0.01% 4041
2016
Q3 		$67K Sell
209
-124
-37% -$45.2K ﹤0.01% 3982
2016
Q2 		$109K Hold
333
– – ﹤0.01% 4041
2016
Q1 		$111K Buy
333
+27
+9% +$9.19K ﹤0.01% 3812
2015
Q4 		$119K Sell
306
-331
-52% -$130K ﹤0.01% 4050
2015
Q3 		$261K Buy
637
+286
+81% +$150K ﹤0.01% 3791
2015
Q2 		$257K Buy
+351
New +$249K ﹤0.01% 4090

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Credit Suisse's CRDF Position: Q3 2022 in Review

Credit Suisse sold out of Cardiff Oncology (CRDF) in Q3 2022, closing a stake of 20 shares.

Credit Suisse first reported a position in CRDF in Q2 2015 and held it in 10 quarters. The position peaked at $1.05M in Q4 2020. 58 funds tracked by Wall St. Rank hold CRDF as of Q3 2022.

  • Credit Suisse reported no remaining Cardiff Oncology position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 20 Cardiff Oncology shares in Q3 2022.
  • Credit Suisse first reported a position in Cardiff Oncology in Q2 2015 and held it in 10 quarters.
  • Credit Suisse's Cardiff Oncology position peaked at $1.05M in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.